XML 19 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Changes in Equity - USD ($)
$ in Thousands
Total
Common Shares
Preferred Shares
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings/(Accumulated deficit)
Cowen Inc Equity
Nonredeemable Noncontrolling Interests
Common stock outstanding, beginning balance (in shares) at Dec. 31, 2020   26,845,628              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Restricted stock awards issued (in shares)   705,512              
Common stock issuance upon acquisition (in shares)   56,801              
Purchase of treasury stock, at cost (in shares)   (755,610)              
Common stock outstanding, ending balance (in shares) at Mar. 31, 2021   26,852,331              
Preferred stock outstanding, beginning balance (in shares) at Dec. 31, 2020     120,750            
Preferred stock outstanding, ending balance (in shares) at Mar. 31, 2021     120,750            
Balance, start at Dec. 31, 2020   $ 334 $ 1 $ (346,870) $ 1,130,138 $ (7) $ 185,901 $ 969,497 $ 199,624
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Purchase of treasury stock, at cost       (26,904)          
Common stock issuance upon acquisition $ 2,202       2,202        
Amortization of share based awards         19,037        
Foreign currency translation           4      
Net income (loss) attributable to Cowen Inc. 147,504           147,504    
Preferred dividends paid             (1,698)    
Cash dividends declared (2,777)           (2,777)    
Net income (loss) attributable to non-controlling interests in consolidated subsidiaries and investment funds                 4,562
Capital contributions                 22,515
Capital withdrawals                 (18,773)
Deconsolidation of entity                 (74,813)
Balance, end at Mar. 31, 2021 1,239,980 $ 334 $ 1 (373,774) 1,151,377 (3) 328,930 1,106,865 133,115
Common stock outstanding, beginning balance (in shares) at Dec. 31, 2021   27,778,964              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Restricted stock awards issued (in shares)   949,803              
Common stock issuance upon acquisition (in shares)   58,587              
Purchase of treasury stock, at cost (in shares)   (1,172,451)              
Common stock outstanding, ending balance (in shares) at Mar. 31, 2022   27,614,903              
Preferred stock outstanding, beginning balance (in shares) at Dec. 31, 2021     0            
Preferred stock outstanding, ending balance (in shares) at Mar. 31, 2022     0            
Balance, start at Dec. 31, 2021 1,175,604 $ 334 $ 0 (547,112) 1,100,667 (2) 461,982 1,015,869 159,735
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Purchase of treasury stock, at cost       (36,423)          
Common stock issuance upon acquisition 1,881       1,881        
Amortization of share based awards         24,612        
Foreign currency translation           2      
Net income (loss) attributable to Cowen Inc. 35,016           35,016    
Preferred dividends paid             (1,698)    
Cash dividends declared (4,111)           (4,111)    
Net income (loss) attributable to non-controlling interests in consolidated subsidiaries and investment funds                 20,131
Capital contributions                 1,610
Capital withdrawals                 (5,901)
Deconsolidation of entity                 0
Balance, end at Mar. 31, 2022 $ 1,210,723 $ 334 $ 0 $ (583,535) $ 1,127,160 $ 0 $ 491,189 $ 1,035,148 $ 175,575